-The Hindu Brazil, Mexico and Thailand have done it. Many countries with a sound understanding of development look at Universal Health Coverage as a vital requirement to achieve it. India is at a crossroads. Introducing UHC in the 12th Plan can transform the lives of Indians, create new jobs and galvanise the economy. Most people would agree that one’s income or caste or gender should not bar one’s ability to get decent...
More »SEARCH RESULT
Total Matching Records found : 861
NSSO figures call Narendra Modi's bluff on malnutrition -Subodh Varma
-The Times of India Whichever way you slice and dice the data, Gujarat chief minister Narendra Modi's statement about causes of malnutrition in the state he has been ruling for over a decade is wrong. In an interview to the Wall Street Journal, Modi had said malnutrition exists in Gujarat because it is "by and large a vegetarian state" and also because it is a middle class state which is "more...
More »Much more than a survival scheme -Aruna Roy & Nikhil Dey
-The Hindu An anthology of independent evaluations of MGNREGA shows that it has provided income security, improved health, narrowed the gender gap and created useful assets In the midst of the debates that prevail in this country over the feasibility of the world’s largest public works programme, the MGNREGA Sameeksha — an anthology of independent research studies and analysis on the Mahatma Gandhi National Rural Employment Guarantee Act, from 2006-2012 — is...
More »A richer approach to poverty reduction -Shailaja Fennel
-The Hindu Business Line India can learn from Brazil’s Bolsa Familia and China’s Gansu Programme to make refinements to its MGNREGA scheme. The development experiences of Brazil, China and India provide a valuable opportunity to understand the relationship between growth and distribution over periods of high rates of growth. The growth story playing out in all the three emerging economies have resulted in large regional as well as spatial inequalities, between rural and...
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »
